What is the approximate market price of the generic version of tazerestat?

Tazemetostat is an anti-tumor drug that targets epigenetics. Its mechanism of action is based on inhibiting EZH2 (enhancer enzyme homolog 2) protein, thereby intervening in the gene expression program of tumor cells. EZH2 is an important enzyme that regulates chromatin remodeling. It is often abnormally activated in tumors such as follicular lymphoma (FL; non-Hodgkin lymphoma) and epithelioid sarcoma (ES; soft tissue sarcoma), which drives tumor progression and recurrence. Tazerestat slows down tumor cell proliferation and induces apoptosis by selectively inhibiting the methyltransferase activity of EZH2. It is especially suitable for patients with EZH2 mutations or EZH2 wild-type patients who still rely on the EZH2 pathway.

In clinical application, tazerestat has shown good oral absorption properties and target selectivity, and is suitable for patients with relapsed or refractory follicular lymphoma who cannot tolerate chemotherapy or have experienced multiple lines of treatment failure, as well as patients with locally advanced or metastatic epithelioid sarcoma. This drug has been approved for marketing in the United States, Europe, Japan and other countries, and is gradually being marketed in China.

With the launch of original drugs, the generic drug market has also quickly followed suit. Currently, the more common generic drugs of tazerestat on the market are produced in Laos such as Lucius Pharmaceutical Factory and Laos Daxiong Pharmaceutical Factory. Their active ingredients are basically the same as the original drugs and comply with the principle of bioequivalence of generic drugs. In terms of market price, the packaging specification of 200mg*56 capsules is usually priced at around RMB 4,000, which is more affordable than the original product and is especially suitable for low- and middle-income patients.

Although the efficacy of generic drugs is similar to that of original drugs, patients still need to choose drugs under the guidance of doctors and ensure that the drug purchase channels are formal and legal. Since it involves targeted precision treatment, quality control factors such as drug stability and dissolution rate directly affect the treatment effect. Patients should avoid purchasing through unknown sources to prevent drug ingredients from substandard or false information.

Reference materials:https://www.tazverik.com/